文献速递创伤骨科

随机临床试验的替代设计:世界髋部创伤评估(WHiTE)平台试验的现状如何?

Alternative designs for randomized clinical trials : where are we now with the World Hip Trauma Evaluation (WHiTE) platform trial?
PubMed 文献 · Bone Joint J · 2025-08-01

世界髋部创伤评估(WHiTE)平台试验将提供随机证据,评估改善脆性髋部骨折患者结局的干预措施的临床与成本效益。本文讨论为何改用平台试验设计以及采用新方法学的试验的潜在优缺点。

要点

  • WHiTE平台试验将提供随机证据评估干预措施的临床与成本效益。
  • 既往WHiTE队列多重嵌入试验模型在提供证据影响国家和国际政策与实践指南方面非常成功。

核心结论

  • WHiTE平台试验将提供随机证据,评估改善脆性髋部骨折患者结局的干预措施的临床与成本效益。

研究设计与样本

  • 本文为述评,讨论为何改用平台试验设计以及采用新方法学的试验的潜在优缺点。

主要发现

  • 既往WHiTE队列多重嵌入试验模型在提供证据影响国家和国际政策与实践指南方面非常成功。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hip fractures present some of the biggest challenges facing patients and healthcare systems. Worldwide, there are currently 1.3 million hip fractures per year, projected to rise to more than six million by 2050. The World Hip Trauma Evaluation (WHiTE) platform trial will provide randomized evidence dealing with the clinical and cost-effectiveness of interventions to improve outcomes for patients with a fragility fracture of the hip. The previous WHiTE cohort multiple-embedded trials' model was highly successful in delivering evidence to inform national and international policy and practice guidelines. This annotation addresses two questions: why change to a platform trial design? And what are the potential advantages and disadvantages of trials which use newer methodologies?

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. Costa ML, Achten J, Appelbe D, et al. Alternative designs for randomized clinical trials : where are we now with the World Hip Trauma Evaluation (WHiTE) platform trial? Bone Joint J. 2025. PMID: 40746115. doi:10.1302/0301-620X.107B8.BJJ-2024-1687.R1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。